158 related articles for article (PubMed ID: 22516918)
1. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
2. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
3. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
4. Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies.
Saellström S; Sharif H; Jagarlamudi KK; Rönnberg H; Wang L; Eriksson S
Res Vet Sci; 2022 Jul; 145():213-221. PubMed ID: 35245727
[TBL] [Abstract][Full Text] [Related]
5. High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in vitro diagnostics.
Kiran Kumar J; Sharif H; Westberg S; von Euler H; Eriksson S
Vet J; 2013 Sep; 197(3):854-60. PubMed ID: 23831216
[TBL] [Abstract][Full Text] [Related]
6. Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra.
Sharif H; Hagman R; Wang L; Eriksson S
Theriogenology; 2013 Jan; 79(1):17-23. PubMed ID: 23102844
[TBL] [Abstract][Full Text] [Related]
7. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
8. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
[TBL] [Abstract][Full Text] [Related]
9. Thymidine kinase assay in canine lymphoma.
Elliott JW; Cripps P; Blackwood L
Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
[TBL] [Abstract][Full Text] [Related]
10. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
[TBL] [Abstract][Full Text] [Related]
12. Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
Jagarlamudi KK; L S; M Z; J O; P V; S E
PLoS One; 2022; 17(10):e0275444. PubMed ID: 36201558
[TBL] [Abstract][Full Text] [Related]
13. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
Jagarlamudi KK; Hansson LO; Eriksson S
BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
[TBL] [Abstract][Full Text] [Related]
14. Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.
Hanan S; Jagarlamudi KK; Liya W; Ellen H; Staffan E
BMC Biochem; 2012 Jun; 13():12. PubMed ID: 22741536
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma.
Sharif H; Saellström S; Kolli B; Jagarlamudi KK; Wang L; Rönnberg H; Eriksson S
Front Vet Sci; 2023; 10():1243853. PubMed ID: 37808109
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma.
Wang L; Unger L; Sharif H; Eriksson S; Gerber V; Rönnberg H
BMC Mol Cell Biol; 2021 Dec; 22(1):59. PubMed ID: 34906077
[TBL] [Abstract][Full Text] [Related]
17. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors.
Kim Y; Park J; Kim B; Yu KR; Kim HS; Oh Y; Seo K; Ryu M; Park C; Bhang D; Choi U; Youn H
J Vet Intern Med; 2024; 38(1):300-307. PubMed ID: 38088206
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
19. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
[TBL] [Abstract][Full Text] [Related]
20. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
